Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Pirbuterol

From Wikipedia, the free encyclopedia
Chemical compound
For other uses, seeMaxair (disambiguation).
Pharmaceutical compound
Pirbuterol
Clinical data
Trade namesMaxair
AHFS/Drugs.comConsumer Drug Information
MedlinePlusa601096
Pregnancy
category
  • C
Routes of
administration
Inhalational (MDI)
ATC code
Legal status
Legal status
Identifiers
  • (RS)-6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC12H20N2O3
Molar mass240.303 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • Oc1ccc(nc1CO)C(O)CNC(C)(C)C
  • InChI=1S/C12H20N2O3/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8/h4-5,11,13,15-17H,6-7H2,1-3H3 checkY
  • Key:VQDBNKDJNJQRDG-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Pirbuterol (trade nameMaxair) is a short-actingβ2 adrenoreceptor agonist withbronchodilating action used in the treatment ofasthma, available (as pirbuterol acetate) as a breath-activatedmetered-dose inhaler.

It was patented in 1971 and came into medical use in 1983.[1]

Medical use

[edit]

Pirbuterol is used in asthma for reversal of acutebronchospasm, and also as a maintenance medication to prevent future attacks. It should be used in patients 12 years of age and older with or without concurrenttheophylline and/or inhaledcorticosteroid.[2][3]

Mode of action

[edit]
Further information:Beta2-adrenergic agonist

Pharmacokinetics

[edit]

After inhalation of doses up to 800μg (twice the maximum recommended dose) systemic blood levels of pirbuterol are below the limit of assay sensitivity (2–5 ng/ml). A mean of 51% of the dose is recovered in urine as pirbuterol plus its sulfate conjugate following administration by aerosol. Pirbuterol is not metabolized bycatechol-O-methyltransferase. The plasma half-life measured after oral administration is about two hours.[2]

Adverse effects

[edit]
Further information:Beta2-adrenergic agonist

References

[edit]
  1. ^Fischer J, Ganellin CR (2006).Analogue-based Drug Discovery. John Wiley & Sons. p. 543.ISBN 9783527607495.
  2. ^ab"Maxair Autohaler (pirbuterol acetate inhalation aerosol) For Oral Inhalation Only. U.S. Full Prescribing Information". 3M Pharmaceuticals. Northridge, CA 91324. Archived fromthe original on 20 September 2018. Retrieved7 March 2016.
  3. ^Bianchi M, Clavenna A, Bonati M (September 2010)."Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period"(PDF).European Journal of Clinical Pharmacology.66 (9):929–36.doi:10.1007/s00228-010-0845-y.PMID 20533030.S2CID 21834280.

External links

[edit]
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Adrenergics,inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
Glucocorticoids
Anticholinergics/
muscarinic antagonist
Mast cell stabilizers
Xanthines
Eicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthinePDE4 inhibitors
Others/unknown
Combination products
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines
(and close relatives)
Miscellaneous
Stub icon

Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Pirbuterol&oldid=1076009443"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp